5347 articles
Dr. Ilias Alevizos, DMD, PhD, Executive Medical Director, Clinical Development at Horizon Therapeutics discusses data from the Phase 2 trial results on
Professor Moshe Szyf, Founder and CEO of HKG Epitherapeutics, discusses epigenetic research, the company's novel tools for early detection of cancer and...
Saad Harti, founder and CEO of Swiss-based biotech Legacy Healthcare discusses the company's positive Phase 2/3 data and filing of their lead prescripti...
Jay Backstrom, MD, MPH, President and CEO, and Ted Myles, COO and CFO of Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company, discusses new...
Reid Merryman, MD, an attending physician in the Lymphoma Program at the Dana-Farber Cancer Institute discusses Genmab and AbbVie's preliminary data fro...
Neda Shamie, partner of the Maloney-Shamie Vision Institute in Los Angeles, discusses the signs, symptoms, and treatment options for cataracts, as well ...
Minaa B., a licensed mental health professional discusses her new book "Owning Our Struggles" an important book advocating for mental health inclusivity.
Returning guest, Allison London Brown, CEO of LUMINELLE discusses LUMINELLE SUSTAINE endoscopic system and the recently FDA-cleared LUMINELLE Bx (Biopsy...
Matthew Old, MD, Director of the Department of Otolaryngology–Head and Neck Surgery at The James, Ohio State University, Comprehensive Cancer Center d...
Jeremy Abramson, Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center an...